Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxone-buprenorphine plus progesterone for prevention of preterm birth in opiate-addicted pregnant women
IRCT20250507065634N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of buprenorphine, naloxone and progesterone, sponsored by Kerman University of Medical Sciences. Started Sep 2025; status: completed.
02
Drugs
buprenorphinenaloxoneprogesterone
Beyond the preview
Go deeper on IRCT20250507065634N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250507065634N1.